NEW YORK (GenomeWeb) – NanoMolecular DX, a firm headed by Nuclea Biotechnologies' former Founder and CEO Patrick Muraca has agreed to purchase the bankrupt company's assets for $330,000.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.
Bloomberg profiles IndieBio, a startup incubator for the life sciences.
In an editorial, Nature calls for the end to the exploitation of foreign postdocs.
In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.